SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-22-004577
Filing Date
2022-01-07
Accepted
2022-01-07 17:15:10
Documents
16

Document Format Files

Seq Description Document Type Size
1 424B4 d501326d424b4.htm 424B4 2172159
2 GRAPHIC g501326g01i20.jpg GRAPHIC 119850
3 GRAPHIC g501326g02y42.jpg GRAPHIC 72508
4 GRAPHIC g501326g03m60.jpg GRAPHIC 92081
5 GRAPHIC g501326g03m99.jpg GRAPHIC 25477
6 GRAPHIC g501326g04m29.jpg GRAPHIC 67257
7 GRAPHIC g501326g10p66.jpg GRAPHIC 53044
8 GRAPHIC g501326g13s54.jpg GRAPHIC 118013
9 GRAPHIC g501326g20d22.jpg GRAPHIC 72332
10 GRAPHIC g501326g21d12.jpg GRAPHIC 59128
11 GRAPHIC g501326g36a89.jpg GRAPHIC 97056
12 GRAPHIC g501326g43c43.jpg GRAPHIC 81304
13 GRAPHIC g501326g47u44.jpg GRAPHIC 97361
14 GRAPHIC g501326g54c54.jpg GRAPHIC 96083
15 GRAPHIC g501326g60n92.jpg GRAPHIC 74253
16 GRAPHIC g501326g87h87.jpg GRAPHIC 62712
  Complete submission text file 0001193125-22-004577.txt   3810997
Mailing Address 200 CLARENDON STREET, 6TH FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 6TH FLOOR BOSTON MA 02116 8445311834
CinCor Pharma, Inc. (Filer) CIK: 0001868734 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-261738 | Film No.: 22518931
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences